文献速递糖尿病肥胖与代谢综合征

体重达标时间占比与超重/肥胖2型糖尿病患者肾脏结局风险的关联

Association of Body Weight Time in Target Range With the Risk of Kidney Outcomes in Patients With Overweight/Obesity and Type 2 Diabetes Mellitus.
PubMed 文献 · Diabetes Care · 2024-01-01

本研究基于Look AHEAD试验中3601例基线eGFR≥60 mL/min/1.73 m2的超重/肥胖2型糖尿病患者,评估前4年体重达标时间占比(TTR,减重≥7%基线体重)与复合肾脏结局的关联。中位随访8.0年共记录435例复合肾脏结局,体重TTR每增加1个标准差,复合肾脏结局风险降低(校正HR 0.81,95%CI 0.70-0.93)。

要点

  • 体重TTR每增加1个标准差,复合肾脏结局风险降低(校正HR 0.81,95%CI 0.70-0.93)。
  • 体重TTR为69.7%至<100%者复合肾脏结局风险最低(校正HR 0.54,95%CI 0.36-0.80)。
  • 尿白蛋白与肌酐比值加倍(次要结局)也呈现类似关联。

核心结论

  • 在超重/肥胖2型糖尿病患者中,以减重≥7%基线体重为目标的较高体重达标时间占比与较低的肾脏结局风险相关。

研究设计与样本

  • 本研究为基于Look AHEAD(Action for Health in Diabetes)试验的分析,纳入3601例基线eGFR≥60 mL/min/1.73 m2的超重/肥胖2型糖尿病患者。
  • 体重达标时间占比定义为前4年内体重处于减重目标(较基线减重≥7%)范围内的时间比例。

主要发现

  • 中位随访8.0年期间,共记录435例复合肾脏结局。
  • 前4年体重达标时间占比与后续复合肾脏结局风险呈负相关(每增加1个标准差;校正HR 0.81;95%CI 0.70-0.93)。
  • 体重达标时间占比为0%、>0%至<29.9%、29.9%至<69.7%、69.7%至<100%的参与者复合肾脏结局校正HR(95%CI)分别为1.00(参照)、0.73(0.54-1.00)、0.71(0.52-0.99)、0.54(0.36-0.80)。
  • 尿白蛋白与肌酐比值加倍(次要结局)也发现类似结果。

关键数值与推荐

  • 复合肾脏结局定义为随访时eGFR较基线下降≥30%且降至<60 mL/min/1.73 m2,或终末期肾病。
  • 体重达标时间占比定义为前4年内体重处于较基线减重≥7%目标范围内的时间比例。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We assessed the relationship of body weight time in target range (TTR) with composite kidney outcome in people with overweight/obesity and type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: Included in this study were 3,601 participants with baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2 from the Look AHEAD (Action for Health in Diabetes) trial. Body weight TTR was defined as the proportion of time during the first 4 years that body weight was within the weight loss target (a weight loss of ≥7% from baseline). The primary outcome was composite kidney outcome, defined as eGFR decline ≥30% from baseline and to a level <60 mL/min/1.73 m2 at follow-up visit, or end-stage kidney disease. RESULTS: During a median follow-up of 8.0 years, 435 cases of composite kidney outcome were documented. Body weight TTR during the first 4 years was inversely associated with the subsequent risk of composite kidney outcome (per SD increment; adjusted hazard ratio [HR] 0.81; 95% CI 0.70-0.93). Accordingly, the adjusted HRs (95% CI) of composite kidney outcome were 1.00 (reference), 0.73 (0.54-1.00), 0.71 (0.52-0.99), and 0.54 (0.36-0.80) for participants with body weight TTR of 0%, >0% to <29.9%, 29.9% to <69.7%, and 69.7% to <100%, respectively. Similar results were found for a doubling of the urine albumin to creatinine ratio (secondary outcome). CONCLUSIONS: A higher body weight TTR, with a weight loss target of losing ≥7% of initial weight, was associated with a lower risk of kidney outcomes in participants with overweight/obesity and T2DM.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Zu C, Liu M, Su X, et al. Association of Body Weight Time in Target Range With the Risk of Kidney Outcomes in Patients With Overweight/Obesity and Type 2 Diabetes Mellitus. Diabetes Care. 2024. PMID: 38079259. doi:10.2337/dc23-1727

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。